Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M Post author:Sam Post published:November 15, 2017 Post category:BioPharma X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace You Might Also Like Regulus Announces Pricing Of Public Offering Of Common Stock July 19, 2017 Novel Material Made Of Living Cells Glows When Touching Certain Chemical Compounds, MIT Study Reveals February 19, 2017 More Deaths Lead Seattle Genetics to Discontinue Phase III Leukemia Study June 18, 2017
Novel Material Made Of Living Cells Glows When Touching Certain Chemical Compounds, MIT Study Reveals February 19, 2017
